Furthermore, Michel Mittelbronn et al. showed EGR1 expression was significantly decreased and associated with enhanced patient survival and was an independent prognostic factor in multivariate analysis in high grade astrocytomas [13]. Here, EGR1 is linked to astrocytoma (excluding glioblastoma).